Chemistry Testing - Cost Per Reportable Result
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | May 6, 2025 |
| Due Date: | May 28, 2025 |
| Solicitation No: | W9114F-25-Q-A035 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Solicitation (Updated)
- Updated Published Date: May 06, 2025 01:57 pm CEST
- Original Published Date: Apr 24, 2025 03:28 pm CEST
- Updated Date Offers Due: May 28, 2025 05:00 pm CEST
- Original Date Offers Due: May 28, 2025 05:00 pm CEST
- Inactive Policy: Manual
- Updated Inactive Date: May 29, 2025
- Original Inactive Date: May 29, 2025
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
ITA
The purpose of amendment W9114F-25-Q-A035-0001 is to:
1. Increase the annual estimated quantity of CPRR to 212,975 for the ordering period in CLIN 0001.
2. Update the ordering period in Exhibit A - contract requirements (paragraph 1.4.) and the CLIN delivery information. The delivery period is 01 July 2025 to 30 June 2030.
3. Update the contract award date in Exhibit B - Projected Implementation Plan. The tentative award date is 01 July 2025.
4. Add Exhibit C - blood chemistry estimated annual workloads.
See Quoters shall provide quotes on the conformed copy of W9114F-25-Q-A035-0001 and sign and return a copy of the SF30 Amendment with their quotes. Both are attached to this notice with updated Exhibits.
The Medical Readiness Contracting Office-Europe requires (1) automated chemistry analyzer and reagents in support of the laboratory mission at U.S. Army Health Clinic - Vicenza in Vicenza, Italy. The successful offeror shall furnish all equipment, reagents, consumables, controls, and any necessary maintenance to the respective laboratories for the purpose of hematology testing under a Cost Per Reportable Result (CPRR) CLIN structure. All parts, equipment and reagents/consumables shall be supplied and serviced through the Contractor.
The resulting contract will be a Fixed-Price (FFP) Indefinite Delivery/ Indefinite Quantity (IDIQ) contract with one (1) five-year ordering period. The anticipated ordering period is approximately 01 July 2025 to 30 June 2030.
See attached 1449 for details. Questions are due no later than 17:00 Central European Time on 8 May 2025.
- MEDICAL READINESS CONTR OFC EUROPE CMR 402
- APO , AE 09180-0402
- USA
- Elena Raspitha
- elena.m.raspitha.civ@health.mil
- Phone Number 49637194644669
- May 06, 2025 01:57 pm CESTSolicitation (Updated)
- May 01, 2025 05:55 am CEST Presolicitation (Updated)
- Apr 24, 2025 03:28 pm CEST Solicitation (Original)
Related Document
| Mar 25, 2025 | [Presolicitation (Original)] Chemistry Testing - Cost Per Reportable Result |
| Apr 23, 2025 | [Presolicitation (Updated)] Chemistry Testing - Cost Per Reportable Result |
| Apr 24, 2025 | [Solicitation (Original)] Chemistry Testing - Cost Per Reportable Result |
| May 14, 2025 | [Solicitation (Updated)] Chemistry Testing - Cost Per Reportable Result |
| Jun 27, 2025 | [Solicitation (Updated)] Chemistry Testing - Cost Per Reportable Result |
See Also
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 10/02/2026